Current Price | $79.80 | Mkt Cap | $3.8B |
---|---|---|---|
Open | $79.62 | P/E Ratio | -15.22 |
Prev. Close | $79.80 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $77.08 - $79.98 | Volume | 487,583 |
52-Wk Range | $55.02 - $98.40 | Avg. Daily Vol. | 766,740 |
Current Price | $79.80 | Mkt Cap | $3.8B |
---|---|---|---|
Open | $79.62 | P/E Ratio | -15.22 |
Prev. Close | $79.80 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $77.08 - $79.98 | Volume | 487,583 |
52-Wk Range | $55.02 - $98.40 | Avg. Daily Vol. | 766,740 |
The best Bull and Bear pitches based on recency and number of recommendations.
Axsome just acquired a drug for sleep disorders -- and that drug saw triple-digit sales growth last year. And Axsome just won FDA approval for a drug for major depressive disorder. This is expected to become a blockbuster. These are two key growth… More
CNS diseases with patient-reported outcomes are so difficult to show efficacy.
Read the most recent pitches from players about AXSM.
Recs
Axsome just acquired a drug for sleep disorders -- and that drug saw triple-digit sales growth last year. And Axsome just won FDA approval for a drug for major depressive disorder. This is expected to become a blockbuster. These are two key growth drivers that are at the beginning of their story.
Recs
The company should benefit from revenue from Sunosi, as well as AXS-05, when that drug is approved.
Recs
They're about to commercialize the world's next blockbuster drug - AXS-05 - and have many others with positive testing results.
Find the members with the highest scoring picks in AXSM.
jeepdrew222 (47.93) Score: +2,888.15
The Score Leader is the player with the highest score across all their picks in AXSM.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
jeepdrew222 | 47.93 | 8/27/2018 | 5Y | $2.60 | +2,969.23% | +81.08% | +2,888.15 | 0 Comment | ||
Under5 | 63.18 |
|
5Y | $2.60 | +2,969.23% | +100.56% | +2,868.67 | 0 Comment | ||
NextGenStock | < 20 |
|
5Y | $3.00 | +2,560.00% | +89.33% | +2,470.67 | 0 Comment | ||
NateVDM214 | < 20 | 6/21/2018 | 3Y | $3.15 | +2,433.33% | +89.55% | +2,343.79 | 0 Comment | ||
jumbofaceplate | < 20 | 5/15/2017 | 5Y | $4.10 | +1,846.34% | +118.43% | +1,727.91 | 0 Comment | ||
ababrmon | 28.51 |
|
5Y | $5.47 | +1,359.19% | +94.96% | +1,264.23 | 0 Comment | ||
warmwind | < 20 | 1/13/2017 | 5Y | $5.50 | +1,350.91% | +130.70% | +1,220.21 | 0 Comment | ||
Momentum21 | 32.40 | 6/2/2016 | 5Y | $7.68 | +939.06% | +148.78% | +790.28 | 0 Comment | ||
Reallynow222 | 85.39 | 2/28/2019 | 5Y | $8.20 | +873.17% | +87.33% | +785.84 | 0 Comment | ||
portefeuille | 97.16 | 1/8/2019 | 5Y | $8.11 | +883.97% | +103.67% | +780.30 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.